SCHEMBL11520379

SCHEMBL11520379

CCCNCc1c(F)cccc1Cl

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.77
▸ KMT2A Q03164 3/20 0.77
▸ SMN1; SMN2 Q16637 1/20 0.77
▸ HTT P42858 2/20 0.64
▸ KDM4E B2RXH2 2/20 0.51
▸ POLB P06746 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.49
▸ ATM Q13315 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ TAAR1 Q96RJ0 1/20 0.49
▸ MAPT P10636 2/20 0.47
▸ GAA P10253 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.44
▸ ERAP1 Q9NZ08 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ GLA P06280 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20414393 0.90 MEN1 (0.88) MEN1KMT2ASMN1; SMN2HTTKDM4E
SCHEMBL26691214 0.88 MEN1 (0.70) MEN1KMT2ASMN1; SMN2HTTKDM4E
SCHEMBL2221552 0.86 MEN1 (0.67) MEN1KMT2ASMN1; SMN2HTTKDM4E
Ammonia Solution, Strong SCHEMBL8149832 0.84 MEN1 (0.65) MEN1KMT2ASMN1; SMN2HTTKDM4E
SCHEMBL3935647 0.78 HTT (0.57) MEN1KMT2ASMN1; SMN2HTTKDM4E
SCHEMBL13900453 0.78 HTT (0.58) MEN1KMT2ASMN1; SMN2HTTKDM4E
SCHEMBL19055370 0.78 HTT (0.58) MEN1KMT2ASMN1; SMN2HTTKDM4E
SCHEMBL23368473 0.76 MEN1 (0.48) MEN1KMT2ASMN1; SMN2HTTKDM4E
SCHEMBL13228082 0.76 TAAR1 (0.68) MEN1KMT2ASMN1; SMN2HTTKDM4E
SCHEMBL21466488 0.76 HTT (0.56) MEN1KMT2ASMN1; SMN2HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896441-B2 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease LYCERA CORPORATION (US) 2018-02-20 — — US disclosed
US-20170183331-A1 TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE WILMINGTON TRUST, NATIONAL ASSOCIATION 2017-06-29 — — US disclosed
US-7741318-B2 Pyrazolo [1,5-A]pyrimidine adenosine A2a receptor antagonists SCHERING CORPORATION (US) 2010-06-22 — — US disclosed
US-7741318-B2 Pyrazolo [1,5-A]pyrimidine adenosine A2a receptor antagonists SCHERING CORPORATION (US) 2010-06-22 — — US disclosed
EP-1836205-B1 PYRAZOLO[1,5-A]PYRIMIDINE ADENOSINE A2a RECEPTOR ANTAGONISTS SCHERING CORP (US) 2009-06-10 — — EP disclosed
US-4147529-A PLANT GROWTH REGULATORS WILCOX MERRILL 1979-04-03 — — US disclosed
US-4116667-A CONTROLLING TOBACCO SUCKERS WILCOX MERRILL 1978-09-26 — — US disclosed
US-4046809-A N-Benzyl-2,6-dinitro-3-amino-4-trifluoromethylanilines as plant growth regulants WILCOX MERRILL 1977-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170183331-A1 TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE RORA, RORB, RORC MEN1 1619/4885KMT2A 939/4885SMN1; SMN2 1570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback